Live Analyst Rating Changes 1315 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Matthew Dellatorre
GS
Matthew Dellatorre
Goldman Sachs
Wall Street Analyst
★★★★☆
#266
on 13Foresight · ranked by our own returns
100%
Success Rate
+30.8%
Average Return
3 of 3 calls profitable · +23.0% vs benchmark
📈 Across the calls we could measure, roughly 100% of Matthew Dellatorre's ratings turned a profit when each position was held for 1 year — averaging +30.8% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

13 Buy 3 Hold 0 Sell
Matthew's Stock Coverage 3 ratings · 2026-06-18
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return
AMRX
Amneal Pharmaceuticals
 May 27, 2026 BUY Strong Buy
+5.9% avg upside
18 analysts
$17.00
4.42% Upside
 +25.8%
TEVA
Teva Pharmaceutical
 Apr 01, 2026 BUY Buy
-8.1% avg upside
39 analysts
$45.00
38.29% Upside
 +11.4%
VTRS
Viatris
 Oct 22, 2025 HOLD Buy
+47.2% avg upside
21 analysts
$12.00
23.71% Downside
 +55.1%
Matthew Dellatorre — Frequently Asked Questions
How accurate are Matthew Dellatorre's stock ratings?
Based on the calls 13Foresight could measure, about 100% of Matthew's ratings were profitable over a one-year hold, with an average return of +30.8% per rating, or +23.0% versus the S&P 500. We score every analyst the same way, from historical prices.
How is Matthew ranked on 13Foresight?
Matthew Dellatorre is currently ranked #266 with a 4-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Matthew cover?
Matthew most recently has ratings on AMRX, TEVA, VTRS. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.